Associated Oxygen（AOL）株式概要アソシエイテッド・オキシジェン・リミテッドは、バングラデシュで工業用ガス、医療用ガス、溶接製品、設備、付帯機器を製造・供給している。 詳細AOL ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長0/6過去の実績0/6財務の健全性0/6配当金2/6リスク分析最新の財務報告は1年以上前のものである 意味のある時価総額がありません ( BDT2B )不安定な配当実績 すべてのリスクチェックを見るAOL Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value৳Current Price৳18.00268.9% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture0557m2016201920222025202620282031Revenue ৳500.4mEarnings ৳46.2mAdvancedSet Fair ValueView all narrativesAssociated Oxygen Limited 競合他社Linde BangladeshSymbol: DSE:LINDEBDMarket cap: ৳10.6bWata ChemicalsSymbol: DSE:WATACHEMMarket cap: ৳2.0bSalvo Organic IndustriesSymbol: DSE:SALVOMarket cap: ৳2.4bLub-rref (Bangladesh)Symbol: DSE:LRBDLMarket cap: ৳1.7b価格と性能株価の高値、安値、推移の概要Associated Oxygen過去の株価現在の株価৳18.0052週高値৳19.5052週安値৳12.50ベータ01ヶ月の変化11.80%3ヶ月変化10.43%1年変化26.76%3年間の変化-50.68%5年間の変化-60.77%IPOからの変化38.67%最新ニュースBoard Change • May 20Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). Independent Director Nasima Chowdhury was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.New Risk • Sep 29New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Bangladeshi stocks, typically moving 8.9% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported March 2023 fiscal period end). Share price has been highly volatile over the past 3 months (8.9% average weekly change). Revenue has declined by 10% over the past year. Minor Risks Revenue is less than US$5m (৳500m revenue, or US$4.2m). Market cap is less than US$100m (৳1.69b market cap, or US$14.1m).Valuation Update With 7 Day Price Move • Sep 26Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to ৳16.90, the stock trades at a trailing P/E ratio of 10.6x. Average trailing P/E is 30x in the Chemicals industry in Bangladesh. Total loss to shareholders of 68% over the past three years.New Risk • Aug 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Bangladeshi stocks, typically moving 7.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported March 2023 fiscal period end). Revenue has declined by 10% over the past year. Minor Risks Share price has been volatile over the past 3 months (7.0% average weekly change). Revenue is less than US$5m (৳500m revenue, or US$4.2m). Market cap is less than US$100m (৳1.98b market cap, or US$16.8m).Valuation Update With 7 Day Price Move • Jul 07Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ৳20.50, the stock trades at a trailing P/E ratio of 12.8x. Average trailing P/E is 28x in the Chemicals industry in Bangladesh. Total loss to shareholders of 53% over the past three years.New Risk • Jun 01New major risk - Financial data availabilityThe company's latest financial reports are more than a year old. Last reported fiscal period ended March 2023. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported March 2023 fiscal period end). Revenue has declined by 10% over the past year. Minor Risks Share price has been volatile over the past 3 months (7.1% average weekly change). Revenue is less than US$5m (৳500m revenue, or US$4.3m). Market cap is less than US$100m (৳2.11b market cap, or US$18.0m).最新情報をもっと見るRecent updatesBoard Change • May 20Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). Independent Director Nasima Chowdhury was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.New Risk • Sep 29New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Bangladeshi stocks, typically moving 8.9% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported March 2023 fiscal period end). Share price has been highly volatile over the past 3 months (8.9% average weekly change). Revenue has declined by 10% over the past year. Minor Risks Revenue is less than US$5m (৳500m revenue, or US$4.2m). Market cap is less than US$100m (৳1.69b market cap, or US$14.1m).Valuation Update With 7 Day Price Move • Sep 26Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to ৳16.90, the stock trades at a trailing P/E ratio of 10.6x. Average trailing P/E is 30x in the Chemicals industry in Bangladesh. Total loss to shareholders of 68% over the past three years.New Risk • Aug 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Bangladeshi stocks, typically moving 7.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported March 2023 fiscal period end). Revenue has declined by 10% over the past year. Minor Risks Share price has been volatile over the past 3 months (7.0% average weekly change). Revenue is less than US$5m (৳500m revenue, or US$4.2m). Market cap is less than US$100m (৳1.98b market cap, or US$16.8m).Valuation Update With 7 Day Price Move • Jul 07Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ৳20.50, the stock trades at a trailing P/E ratio of 12.8x. Average trailing P/E is 28x in the Chemicals industry in Bangladesh. Total loss to shareholders of 53% over the past three years.New Risk • Jun 01New major risk - Financial data availabilityThe company's latest financial reports are more than a year old. Last reported fiscal period ended March 2023. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported March 2023 fiscal period end). Revenue has declined by 10% over the past year. Minor Risks Share price has been volatile over the past 3 months (7.1% average weekly change). Revenue is less than US$5m (৳500m revenue, or US$4.3m). Market cap is less than US$100m (৳2.11b market cap, or US$18.0m).New Risk • Mar 31New major risk - Revenue and earnings growthRevenue has declined by 10% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Revenue has declined by 10% over the past year. Minor Risks Latest financial reports are more than 6 months old (reported March 2023 fiscal period end). Share price has been volatile over the past 3 months (7.7% average weekly change). Revenue is less than US$5m (৳500m revenue, or US$4.5m). Market cap is less than US$100m (৳2.69b market cap, or US$24.4m).New Risk • Mar 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Bangladeshi stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported March 2023 fiscal period end). Share price has been volatile over the past 3 months (7.5% average weekly change). Revenue is less than US$5m (৳500m revenue, or US$4.6m). Market cap is less than US$100m (৳3.18b market cap, or US$29.0m).Valuation Update With 7 Day Price Move • Jan 23Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ৳30.50, the stock trades at a trailing P/E ratio of 19.1x. Average trailing P/E is 31x in the Chemicals industry in Bangladesh. Total loss to shareholders of 23% over the past three years.Upcoming Dividend • Jan 21Upcoming dividend of ৳0.10 per share at 2.7% yieldEligible shareholders must have bought the stock before 28 January 2024. Payment date: 19 March 2024. Trailing yield: 2.7%. Lower than top quartile of Bangladeshi dividend payers (3.3%). Higher than average of industry peers (2.1%).お知らせ • Jan 09+ 1 more updateAssociated Oxygen Limited, Annual General Meeting, Feb 18, 2024Associated Oxygen Limited, Annual General Meeting, Feb 18, 2024, at 15:00 Bangladesh Standard Time.お知らせ • Dec 29Associated Oxygen Limited to Report Q4, 2023 Results on Jan 04, 2024Associated Oxygen Limited announced that they will report Q4, 2023 results on Jan 04, 2024New Risk • Dec 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported March 2023 fiscal period end). Paying a dividend despite having no free cash flows. Revenue is less than US$5m (৳500m revenue, or US$4.6m). Market cap is less than US$100m (৳4.01b market cap, or US$36.5m).Board Change • Oct 31Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). Independent Director Nasima Chowdhury was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Jun 02Third quarter 2023 earnings released: EPS: ৳0.52 (vs ৳0.46 in 3Q 2022)Third quarter 2023 results: EPS: ৳0.52 (up from ৳0.46 in 3Q 2022). Revenue: ৳150.1m (up 8.5% from 3Q 2022). Net income: ৳56.8m (up 12% from 3Q 2022). Profit margin: 38% (up from 37% in 3Q 2022). The increase in margin was driven by higher revenue.お知らせ • May 23Associated Oxygen Limited to Report Q3, 2023 Results on May 25, 2023Associated Oxygen Limited announced that they will report Q3, 2023 results on May 25, 2023Reported Earnings • Dec 15First quarter 2023 earnings released: EPS: ৳0.41 (vs ৳0.46 in 1Q 2022)First quarter 2023 results: EPS: ৳0.41 (down from ৳0.46 in 1Q 2022). Revenue: ৳120.5m (down 14% from 1Q 2022). Net income: ৳45.3m (down 10.0% from 1Q 2022). Profit margin: 38% (up from 36% in 1Q 2022). The increase in margin was driven by lower expenses.Upcoming Dividend • Nov 24Upcoming dividend of ৳1.00 per shareEligible shareholders must have bought the stock before 01 December 2022. Payment date: 29 January 2023. Payout ratio is a comfortable 25% but the company is not cash flow positive. Trailing yield: 2.7%. Lower than top quartile of Bangladeshi dividend payers (3.8%). Higher than average of industry peers (2.4%).Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). Independent Director Nasima Chowdhury was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.お知らせ • Nov 09Associated Oxygen Limited Recommends Cash Dividend PaymentAssociated Oxygen Limited has recommended 10% Cash dividend for general shareholders only excluding sponsors and directors for the year ended June 30, 2022. Sponsors and directors hold 3,36,55,905 shares out of total 10,97,82,000 shares and cash dividend payable to general shareholders is Tk. 7,61,26,095.00.Valuation Update With 7 Day Price Move • Sep 25Investor sentiment improved over the past weekAfter last week's 16% share price gain to ৳44.70, the stock trades at a trailing P/E ratio of 23.6x. Average trailing P/E is 26x in the Chemicals industry in Bangladesh. Total loss to shareholders of 16% over the past year.Buying Opportunity • Apr 28Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 3.7%. The fair value is estimated to be ৳47.41, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has grown by 13%.Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Director Nasima Chowdhury was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Buying Opportunity • Apr 18Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 8.2%. The fair value is estimated to be ৳47.25, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has grown by 13%.Valuation Update With 7 Day Price Move • Mar 15Investor sentiment improved over the past weekAfter last week's 17% share price gain to ৳44.50, the stock trades at a trailing P/E ratio of 23x. Average trailing P/E is 28x in the Chemicals industry in Bangladesh. Total returns to shareholders of 24% over the past year.Reported Earnings • Feb 09Second quarter 2022 earnings: Revenues and EPS in line with analyst expectationsSecond quarter 2022 results: EPS: ৳0.45 (down from ৳0.51 in 2Q 2021). Revenue: ৳134.7m (down 7.0% from 2Q 2021). Net income: ৳45.8m (down 17% from 2Q 2021). Profit margin: 34% (down from 38% in 2Q 2021). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates.Reported Earnings • Nov 26First quarter 2022 earnings: Revenues and EPS in line with analyst expectationsFirst quarter 2022 results: EPS: ৳0.49 (down from ৳0.50 in 1Q 2021). Revenue: ৳140.3m (up 9.5% from 1Q 2021). Net income: ৳50.3m (up 16% from 1Q 2021). Profit margin: 36% (up from 34% in 1Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates.Upcoming Dividend • Nov 21Upcoming dividend of ৳0.50 per shareEligible shareholders must have bought the stock before 28 November 2021. Payment date: 23 January 2022. Trailing yield: 1.1%. Lower than top quartile of Bangladeshi dividend payers (2.9%). Lower than average of industry peers (2.0%).Valuation Update With 7 Day Price Move • Aug 22Investor sentiment improved over the past weekAfter last week's 16% share price gain to ৳61.00, the stock trades at a trailing P/E ratio of 28.8x. Average trailing P/E is 35x in the Chemicals industry in Bangladesh.Valuation Update With 7 Day Price Move • Jun 16Investor sentiment improved over the past weekAfter last week's 17% share price gain to ৳55.10, the stock trades at a trailing P/E ratio of 26x. Average trailing P/E is 33x in the Chemicals industry in Bangladesh.Reported Earnings • Jun 05Third quarter 2021 earnings released: EPS ৳0.54 (vs ৳0.47 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ৳147.1m (up 13% from 3Q 2020). Net income: ৳55.3m (up 36% from 3Q 2020). Profit margin: 38% (up from 31% in 3Q 2020). The increase in margin was driven by higher revenue.Valuation Update With 7 Day Price Move • Apr 27Investor sentiment improved over the past weekAfter last week's 18% share price gain to ৳47.20, the stock trades at a trailing P/E ratio of 24.3x. Average trailing P/E is 33x in the Chemicals industry in Bangladesh.Valuation Update With 7 Day Price Move • Mar 01Investor sentiment improved over the past weekAfter last week's 15% share price gain to ৳40.20, the stock is trading at a trailing P/E ratio of 20.7x, up from the previous P/E ratio of 18x. This compares to an average P/E of 34x in the Chemicals industry in Bangladesh.Is New 90 Day High Low • Feb 23New 90-day low: ৳34.90The company is down 35% from its price of ৳53.98 on 24 November 2020. The Bangladeshi market is up 15% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 9.0% over the same period.Valuation Update With 7 Day Price Move • Feb 04Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ৳37.00, the stock is trading at a trailing P/E ratio of 19x, down from the previous P/E ratio of 22.6x. This compares to an average P/E of 33x in the Chemicals industry in Bangladesh.Reported Earnings • Feb 03Second quarter 2021 earnings released: EPS ৳0.55 (vs ৳0.41 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: ৳144.8m (up 17% from 2Q 2020). Net income: ৳54.9m (up 51% from 2Q 2020). Profit margin: 38% (up from 29% in 2Q 2020). The increase in margin was driven by higher revenue.Is New 90 Day High Low • Feb 03New 90-day low: ৳39.10The company is down 16% from its price of ৳46.48 on 05 November 2020. The Bangladeshi market is up 15% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 8.0% over the same period.Valuation Update With 7 Day Price Move • Jan 18Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ৳44.10, the stock is trading at a trailing P/E ratio of 22.1x, down from the previous P/E ratio of 26.5x. This compares to an average P/E of 37x in the Chemicals industry in Bangladesh.Reported Earnings • Dec 12First quarter 2021 earnings released: EPS ৳0.55The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: ৳128.1m (up 10.0% from 1Q 2020). Net income: ৳43.6m (up 30% from 1Q 2020). Profit margin: 34% (up from 29% in 1Q 2020). The increase in margin was driven by higher revenue.お知らせ • Nov 06Associated Oxygen Limited, Annual General Meeting, Dec 22, 2020Associated Oxygen Limited, Annual General Meeting, Dec 22, 2020, at 15:30 Bangladesh Standard Time. Agenda: To approve dividend.株主還元AOLBD ChemicalsBD 市場7D-2.2%0.09%0.7%1Y26.8%-11.8%10.0%株主還元を見る業界別リターン: AOL過去 1 年間で-11.8 % の収益を上げたBD Chemicals業界を上回りました。リターン対市場: AOL過去 1 年間で10 % の収益を上げたBD市場を上回りました。価格変動Is AOL's price volatile compared to industry and market?AOL volatilityAOL Average Weekly Movement4.3%Chemicals Industry Average Movement4.8%Market Average Movement4.9%10% most volatile stocks in BD Market7.5%10% least volatile stocks in BD Market2.7%安定した株価: AOL 、 BD市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: AOLの 週次ボラティリティ ( 4% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト1990n/aIsmat Jahanwww.associatedoxygenltd.comアソシエイテッド・オキシジェン・リミテッドは、バングラデシュで工業用・医療用ガス、溶接製品、機器、付帯設備を製造・供給している。同社は販売ネットワークを通じて、液体および気体状の酸素と窒素を産業や病院に提供している。同社の製品は、金属ガス溶接、切断、ろう付け、金属、石油・ガス、化学・石油化学、養殖、廃棄物管理、ガラス産業で使用されている。同社は1990年に設立され、バングラデシュのチッタゴンに本社を置いている。もっと見るAssociated Oxygen Limited 基礎のまとめAssociated Oxygen の収益と売上を時価総額と比較するとどうか。AOL 基礎統計学時価総額৳1.98b収益（TTM）৳175.19m売上高(TTM)৳500.42m0.0xPER（株価収益率0.0xP/SレシオAOL は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計AOL 損益計算書（TTM）収益৳500.42m売上原価৳183.35m売上総利益৳317.07mその他の費用৳141.88m収益৳175.19m直近の収益報告Mar 31, 2023次回決算日該当なし一株当たり利益（EPS）0グロス・マージン0.00%純利益率0.00%有利子負債／自己資本比率0.0%AOL の長期的なパフォーマンスは？過去の実績と比較を見る配当金5.6%現在の配当利回りn/a配当性向View Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/17 01:16終値2026/06/17 00:00収益2023/03/31年間収益2022/06/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Associated Oxygen Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Board Change • May 20Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). Independent Director Nasima Chowdhury was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
New Risk • Sep 29New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Bangladeshi stocks, typically moving 8.9% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported March 2023 fiscal period end). Share price has been highly volatile over the past 3 months (8.9% average weekly change). Revenue has declined by 10% over the past year. Minor Risks Revenue is less than US$5m (৳500m revenue, or US$4.2m). Market cap is less than US$100m (৳1.69b market cap, or US$14.1m).
Valuation Update With 7 Day Price Move • Sep 26Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to ৳16.90, the stock trades at a trailing P/E ratio of 10.6x. Average trailing P/E is 30x in the Chemicals industry in Bangladesh. Total loss to shareholders of 68% over the past three years.
New Risk • Aug 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Bangladeshi stocks, typically moving 7.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported March 2023 fiscal period end). Revenue has declined by 10% over the past year. Minor Risks Share price has been volatile over the past 3 months (7.0% average weekly change). Revenue is less than US$5m (৳500m revenue, or US$4.2m). Market cap is less than US$100m (৳1.98b market cap, or US$16.8m).
Valuation Update With 7 Day Price Move • Jul 07Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ৳20.50, the stock trades at a trailing P/E ratio of 12.8x. Average trailing P/E is 28x in the Chemicals industry in Bangladesh. Total loss to shareholders of 53% over the past three years.
New Risk • Jun 01New major risk - Financial data availabilityThe company's latest financial reports are more than a year old. Last reported fiscal period ended March 2023. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported March 2023 fiscal period end). Revenue has declined by 10% over the past year. Minor Risks Share price has been volatile over the past 3 months (7.1% average weekly change). Revenue is less than US$5m (৳500m revenue, or US$4.3m). Market cap is less than US$100m (৳2.11b market cap, or US$18.0m).
Board Change • May 20Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). Independent Director Nasima Chowdhury was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
New Risk • Sep 29New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Bangladeshi stocks, typically moving 8.9% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported March 2023 fiscal period end). Share price has been highly volatile over the past 3 months (8.9% average weekly change). Revenue has declined by 10% over the past year. Minor Risks Revenue is less than US$5m (৳500m revenue, or US$4.2m). Market cap is less than US$100m (৳1.69b market cap, or US$14.1m).
Valuation Update With 7 Day Price Move • Sep 26Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to ৳16.90, the stock trades at a trailing P/E ratio of 10.6x. Average trailing P/E is 30x in the Chemicals industry in Bangladesh. Total loss to shareholders of 68% over the past three years.
New Risk • Aug 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Bangladeshi stocks, typically moving 7.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported March 2023 fiscal period end). Revenue has declined by 10% over the past year. Minor Risks Share price has been volatile over the past 3 months (7.0% average weekly change). Revenue is less than US$5m (৳500m revenue, or US$4.2m). Market cap is less than US$100m (৳1.98b market cap, or US$16.8m).
Valuation Update With 7 Day Price Move • Jul 07Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ৳20.50, the stock trades at a trailing P/E ratio of 12.8x. Average trailing P/E is 28x in the Chemicals industry in Bangladesh. Total loss to shareholders of 53% over the past three years.
New Risk • Jun 01New major risk - Financial data availabilityThe company's latest financial reports are more than a year old. Last reported fiscal period ended March 2023. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported March 2023 fiscal period end). Revenue has declined by 10% over the past year. Minor Risks Share price has been volatile over the past 3 months (7.1% average weekly change). Revenue is less than US$5m (৳500m revenue, or US$4.3m). Market cap is less than US$100m (৳2.11b market cap, or US$18.0m).
New Risk • Mar 31New major risk - Revenue and earnings growthRevenue has declined by 10% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Revenue has declined by 10% over the past year. Minor Risks Latest financial reports are more than 6 months old (reported March 2023 fiscal period end). Share price has been volatile over the past 3 months (7.7% average weekly change). Revenue is less than US$5m (৳500m revenue, or US$4.5m). Market cap is less than US$100m (৳2.69b market cap, or US$24.4m).
New Risk • Mar 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Bangladeshi stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported March 2023 fiscal period end). Share price has been volatile over the past 3 months (7.5% average weekly change). Revenue is less than US$5m (৳500m revenue, or US$4.6m). Market cap is less than US$100m (৳3.18b market cap, or US$29.0m).
Valuation Update With 7 Day Price Move • Jan 23Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ৳30.50, the stock trades at a trailing P/E ratio of 19.1x. Average trailing P/E is 31x in the Chemicals industry in Bangladesh. Total loss to shareholders of 23% over the past three years.
Upcoming Dividend • Jan 21Upcoming dividend of ৳0.10 per share at 2.7% yieldEligible shareholders must have bought the stock before 28 January 2024. Payment date: 19 March 2024. Trailing yield: 2.7%. Lower than top quartile of Bangladeshi dividend payers (3.3%). Higher than average of industry peers (2.1%).
お知らせ • Jan 09+ 1 more updateAssociated Oxygen Limited, Annual General Meeting, Feb 18, 2024Associated Oxygen Limited, Annual General Meeting, Feb 18, 2024, at 15:00 Bangladesh Standard Time.
お知らせ • Dec 29Associated Oxygen Limited to Report Q4, 2023 Results on Jan 04, 2024Associated Oxygen Limited announced that they will report Q4, 2023 results on Jan 04, 2024
New Risk • Dec 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported March 2023 fiscal period end). Paying a dividend despite having no free cash flows. Revenue is less than US$5m (৳500m revenue, or US$4.6m). Market cap is less than US$100m (৳4.01b market cap, or US$36.5m).
Board Change • Oct 31Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). Independent Director Nasima Chowdhury was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Jun 02Third quarter 2023 earnings released: EPS: ৳0.52 (vs ৳0.46 in 3Q 2022)Third quarter 2023 results: EPS: ৳0.52 (up from ৳0.46 in 3Q 2022). Revenue: ৳150.1m (up 8.5% from 3Q 2022). Net income: ৳56.8m (up 12% from 3Q 2022). Profit margin: 38% (up from 37% in 3Q 2022). The increase in margin was driven by higher revenue.
お知らせ • May 23Associated Oxygen Limited to Report Q3, 2023 Results on May 25, 2023Associated Oxygen Limited announced that they will report Q3, 2023 results on May 25, 2023
Reported Earnings • Dec 15First quarter 2023 earnings released: EPS: ৳0.41 (vs ৳0.46 in 1Q 2022)First quarter 2023 results: EPS: ৳0.41 (down from ৳0.46 in 1Q 2022). Revenue: ৳120.5m (down 14% from 1Q 2022). Net income: ৳45.3m (down 10.0% from 1Q 2022). Profit margin: 38% (up from 36% in 1Q 2022). The increase in margin was driven by lower expenses.
Upcoming Dividend • Nov 24Upcoming dividend of ৳1.00 per shareEligible shareholders must have bought the stock before 01 December 2022. Payment date: 29 January 2023. Payout ratio is a comfortable 25% but the company is not cash flow positive. Trailing yield: 2.7%. Lower than top quartile of Bangladeshi dividend payers (3.8%). Higher than average of industry peers (2.4%).
Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). Independent Director Nasima Chowdhury was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
お知らせ • Nov 09Associated Oxygen Limited Recommends Cash Dividend PaymentAssociated Oxygen Limited has recommended 10% Cash dividend for general shareholders only excluding sponsors and directors for the year ended June 30, 2022. Sponsors and directors hold 3,36,55,905 shares out of total 10,97,82,000 shares and cash dividend payable to general shareholders is Tk. 7,61,26,095.00.
Valuation Update With 7 Day Price Move • Sep 25Investor sentiment improved over the past weekAfter last week's 16% share price gain to ৳44.70, the stock trades at a trailing P/E ratio of 23.6x. Average trailing P/E is 26x in the Chemicals industry in Bangladesh. Total loss to shareholders of 16% over the past year.
Buying Opportunity • Apr 28Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 3.7%. The fair value is estimated to be ৳47.41, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has grown by 13%.
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Director Nasima Chowdhury was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Buying Opportunity • Apr 18Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 8.2%. The fair value is estimated to be ৳47.25, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has grown by 13%.
Valuation Update With 7 Day Price Move • Mar 15Investor sentiment improved over the past weekAfter last week's 17% share price gain to ৳44.50, the stock trades at a trailing P/E ratio of 23x. Average trailing P/E is 28x in the Chemicals industry in Bangladesh. Total returns to shareholders of 24% over the past year.
Reported Earnings • Feb 09Second quarter 2022 earnings: Revenues and EPS in line with analyst expectationsSecond quarter 2022 results: EPS: ৳0.45 (down from ৳0.51 in 2Q 2021). Revenue: ৳134.7m (down 7.0% from 2Q 2021). Net income: ৳45.8m (down 17% from 2Q 2021). Profit margin: 34% (down from 38% in 2Q 2021). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates.
Reported Earnings • Nov 26First quarter 2022 earnings: Revenues and EPS in line with analyst expectationsFirst quarter 2022 results: EPS: ৳0.49 (down from ৳0.50 in 1Q 2021). Revenue: ৳140.3m (up 9.5% from 1Q 2021). Net income: ৳50.3m (up 16% from 1Q 2021). Profit margin: 36% (up from 34% in 1Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates.
Upcoming Dividend • Nov 21Upcoming dividend of ৳0.50 per shareEligible shareholders must have bought the stock before 28 November 2021. Payment date: 23 January 2022. Trailing yield: 1.1%. Lower than top quartile of Bangladeshi dividend payers (2.9%). Lower than average of industry peers (2.0%).
Valuation Update With 7 Day Price Move • Aug 22Investor sentiment improved over the past weekAfter last week's 16% share price gain to ৳61.00, the stock trades at a trailing P/E ratio of 28.8x. Average trailing P/E is 35x in the Chemicals industry in Bangladesh.
Valuation Update With 7 Day Price Move • Jun 16Investor sentiment improved over the past weekAfter last week's 17% share price gain to ৳55.10, the stock trades at a trailing P/E ratio of 26x. Average trailing P/E is 33x in the Chemicals industry in Bangladesh.
Reported Earnings • Jun 05Third quarter 2021 earnings released: EPS ৳0.54 (vs ৳0.47 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ৳147.1m (up 13% from 3Q 2020). Net income: ৳55.3m (up 36% from 3Q 2020). Profit margin: 38% (up from 31% in 3Q 2020). The increase in margin was driven by higher revenue.
Valuation Update With 7 Day Price Move • Apr 27Investor sentiment improved over the past weekAfter last week's 18% share price gain to ৳47.20, the stock trades at a trailing P/E ratio of 24.3x. Average trailing P/E is 33x in the Chemicals industry in Bangladesh.
Valuation Update With 7 Day Price Move • Mar 01Investor sentiment improved over the past weekAfter last week's 15% share price gain to ৳40.20, the stock is trading at a trailing P/E ratio of 20.7x, up from the previous P/E ratio of 18x. This compares to an average P/E of 34x in the Chemicals industry in Bangladesh.
Is New 90 Day High Low • Feb 23New 90-day low: ৳34.90The company is down 35% from its price of ৳53.98 on 24 November 2020. The Bangladeshi market is up 15% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 9.0% over the same period.
Valuation Update With 7 Day Price Move • Feb 04Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ৳37.00, the stock is trading at a trailing P/E ratio of 19x, down from the previous P/E ratio of 22.6x. This compares to an average P/E of 33x in the Chemicals industry in Bangladesh.
Reported Earnings • Feb 03Second quarter 2021 earnings released: EPS ৳0.55 (vs ৳0.41 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: ৳144.8m (up 17% from 2Q 2020). Net income: ৳54.9m (up 51% from 2Q 2020). Profit margin: 38% (up from 29% in 2Q 2020). The increase in margin was driven by higher revenue.
Is New 90 Day High Low • Feb 03New 90-day low: ৳39.10The company is down 16% from its price of ৳46.48 on 05 November 2020. The Bangladeshi market is up 15% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 8.0% over the same period.
Valuation Update With 7 Day Price Move • Jan 18Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ৳44.10, the stock is trading at a trailing P/E ratio of 22.1x, down from the previous P/E ratio of 26.5x. This compares to an average P/E of 37x in the Chemicals industry in Bangladesh.
Reported Earnings • Dec 12First quarter 2021 earnings released: EPS ৳0.55The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: ৳128.1m (up 10.0% from 1Q 2020). Net income: ৳43.6m (up 30% from 1Q 2020). Profit margin: 34% (up from 29% in 1Q 2020). The increase in margin was driven by higher revenue.
お知らせ • Nov 06Associated Oxygen Limited, Annual General Meeting, Dec 22, 2020Associated Oxygen Limited, Annual General Meeting, Dec 22, 2020, at 15:30 Bangladesh Standard Time. Agenda: To approve dividend.
